Advanced Solutions Life Sciences

KY - LouisvilleBiotechnology1 H-1B visas (FY2023)

Focus: Advanced Solutions Life Sciences is a micro-cap biotech specializing in tissue handling products and medical gases (nitrous oxide, nitrogen, helium, oxygen, medical air). The company operates as a public entity from Louisville, KY with 1-50 employees.

Respiratory Oncology Metabolic Diseases Infectious Diseases

Profile data last refreshed 2d ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Employees

1-50

Open Jobs

About Advanced Solutions Life Sciences

AI assessmentNot Hiring

No open roles listed right now. Follow Advanced Solutions Life Sciences to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

3 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

NITROUS OXIDE, USP

Not specified

Peak

Approved medical gas product in peak lifecycle stage; indicates regulatory footprint but limited commercial details available.

Help build intelligence for Advanced Solutions Life Sciences

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage innovation in medical gas delivery and impedance threshold devices with Phase 2 pipeline programs in hypotension and cerebral perfusion
Opportunity to build foundational operations and processes in a 1-50 person organization with meaningful equity potential
Public company status provides regulatory visibility and potential exit liquidity versus private pre-revenue peers

Watch Out For

Zero active job openings and minimal hiring activity indicates limited near-term growth or expansion plans
Extremely small team (1-50 employees) suggests limited career development infrastructure, mentorship, and functional specialization
Early-stage pipeline (only Phase 2 programs) with no Phase 3 catalysts or revenue visibility creates significant commercial execution risk

Generated by Claude from Advanced Solutions Life Sciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.